A possible reason for this insensitivity is that ERK5 nuclear accumulation, a crucial event in sustaining cancer cell proliferation [77], is indeed often independent of the kinase activity of MEK5 or ERK5 itself as indicated by the ineffectiveness of ERK5 or MEK5 inhibitors when used as single agents. Here, MAPK7 is linked to cancer.